Literature DB >> 14531737

Gastrointestinal cancers in Europe.

M R B Keighley1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14531737     DOI： 10.1046/j.0953-0673.2003.01722.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  34 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Colorectal cancer prevention.

Authors:  M Andreu; M Marzo; J Mascort; E Quintero; P García-Alfonso; C López-Ibor; T Castells; P Pérez Segura
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

3.  [Prevention of colorectal cancer].

Authors:  Montserrat Andreu García; Mercè Marzo; Juanjo Mascort; Enrique Quintero; Pilar García-Alfonso; Cristina López-Ibor; Antoni Castells; Pedro Pérez Segura
Journal:  Aten Primaria       Date:  2009-03-21       Impact factor: 1.137

Review 4.  Prognostic value of HIF-1α expression in patients with gastric cancer.

Authors:  Cheng-lin Zhu; Qiang Huang; Chen-hai Liu; Xian-sheng Lin; Fang Xie
Journal:  Mol Biol Rep       Date:  2013-09-23       Impact factor: 2.316

5.  siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.

Authors:  Wen-Song Liu; Hai-Jiao Yan; Ren-Yi Qin; Rui Tian; Min Wang; Jian-Xin Jiang; Ming Shen; Cheng-Jian Shi
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

6.  Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.

Authors:  Francesco Giganti; Alessandro Ambrosi; Maria C Petrone; Carla Canevari; Damiano Chiari; Annalaura Salerno; Paolo G Arcidiacono; Roberto Nicoletti; Luca Albarello; Elena Mazza; Francesca Gallivanone; Luigi Gianolli; Elena Orsenigo; Antonio Esposito; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Br J Radiol       Date:  2016-10-21       Impact factor: 3.039

7.  Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer.

Authors:  Hanan Ahmed Wahba; Hend Ahmed El-Hadaad; Ehab Atef Abd-Ellatif
Journal:  Med Oncol       Date:  2011-06-26       Impact factor: 3.064

8.  The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).

Authors:  Odré Palie; Pierre Michel; Jean-François Ménard; Caroline Rousseau; Emmanuel Rio; Boumédiene Bridji; Ahmed Benyoucef; Marc-Etienne Meyer; Khadija Jalali; Stéphane Bardet; Che Mabubu M'vondo; Pierre Olivier; Guillaume Faure; Emmanuel Itti; Christian Diana; Claire Houzard; Françoise Mornex; Frederic Di Fiore; Pierre Vera
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-29       Impact factor: 9.236

9.  Histopathologic Prolife of Primary Gastrointestinal Malignancies in Uyo City (Niger-Delta Region of Nigeria).

Authors:  Emmanuel K Abudu; Oluyinka S Akinbami
Journal:  Rare Tumors       Date:  2016-04-06

10.  Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin.

Authors:  S Bafna; S Kaur; N Momi; S K Batra
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.